ST2: a novel biomarker for heart failure

References

• Lloyd-Jones D, Adams RJ, Brown TM. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation119(3), 480–486 (2009).
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J.29(19), 2388–2442 (2008).
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Corday E. ADHERE Scientific Advisory Committee. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail. Rev.9(3), 179–185 (2004).
   PubMed Web of Science ®Google Scholar
• Kakkar R, Lee RT. ST2 and adrenomedullin in heart failure. Heart Fail. Clin.5(4), 515–527 (2009).
   PubMedGoogle Scholar
• Dieplinger B, Gegenhuber A, Haltmayer M et al. Evaluation of novel biomarkers for the diagnosis of acute destabilized heart failure in patients with shortness of breath. Heart95(18), 1508–1513 (2009).
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Shimpo M, De Keulenaer GW et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation106(23), 2961–2966 (2002).
   PubMed Web of Science ®Google Scholar
• McKinsey TA, Olson EN. Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J. Clin. Invest.115(3), 538–546 (2005).
   PubMed Web of Science ®Google Scholar
• Manabe I, Shindo T, Nagai R. Gene Expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res.91(12), 1103–1113 (2002).
   PubMed Web of Science ®Google Scholar
• Iwahana H, Yanagisawa K, Ito-Kosaka A et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. Eur. J. Biochem.264(2), 397–406 (1999).
   PubMedGoogle Scholar
• Sanada S, Hakuno D, Higgins L et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J. Clin. Invest.117(6), 1538–1549 (2007).
   PubMed Web of Science ®Google Scholar
• Barksby HE, Lea SR, Preshaw PM et al. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin. Exp. Immunol.149(2), 217–225 (2007).
   PubMed Web of Science ®Google Scholar
• Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor – related protein ST2 and induces T helper type 2-associated cytokines. Immunity23(5), 479–490 (2005).
   PubMed Web of Science ®Google Scholar
• Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov.7(10), 827–840 (2008).
   PubMed Web of Science ®Google Scholar
• Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ. Res.73(1), 184–192 (1993).
   PubMed Web of Science ®Google Scholar
• Weinberg EO, Shimpo M, Hurwitz S, Tominaga SI, Rouleau JL, Lee RT. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation2003 107(5), 721–726 (2003).
   Google Scholar
• Shah RV, Chen-Tournoux AA, Picard MH, van Kimmenade RR, Januzzi JL. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ. Heart Fail.2(4), 311–319 (2009).
   PubMed Web of Science ®Google Scholar
• Sweet MJ, Leung BP, Kang D et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol.166(11), 6633–6639 (2001).
   PubMed Web of Science ®Google Scholar
• Januzzi JL, Peacock WF, Maisel AS et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J. Am. Coll. Cardiol.50(7), 607–613 (2007).
   PubMed Web of Science ®Google Scholar
• Rehman SU, Mueller T, Januzzi JL. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J. Am. Coll. Cardiol.52(18), 1458–1465 (2008).
   PubMed Web of Science ®Google Scholar
• Rehman SU, Martinez-Rumayor A, Mueller T, Januzzi JL Jr. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin. Chim. Acta392(1–2), 41–45 (2008).
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B, Gegenhuber A et al. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Clin. Chem.54(4), 752–756 (2008).
   PubMed Web of Science ®Google Scholar
• Boisot S, Beede J, Isakson S et al. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J. Card. Fail.14(9), 732–738 (2008).
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J. Am. Coll. Cardiol.54(23), 2174–2179 (2009).
   PubMed Web of Science ®Google Scholar
• Shimpo M, Morrow DA, Weinberg EO et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation109(18), 2186–2190 (2004).
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Higgins LJ et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation117(15), 1936–1944 (2008).
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr, Camargo CA, Anwaruddin S et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol.95(8), 948–954 (2005).
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Januzzi JL, Steinmair M et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma – the Presage ST2 assay. Clin. Chim. Acta409(1–2), 33–40 (2009).
   PubMed Web of Science ®Google Scholar
• Martinez-Rumayor A, Camargo CA, Green SM, Baggish AL, O’Donoghue M, Januzzi JL. Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease. Am. J. Clin. Pathol.130(4), 578–584 (2008).
   PubMed Web of Science ®Google Scholar